AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] STERIS plc Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Mohsen Sohi, a director of STERIS plc (STE), reported multiple equity transactions in August 2025. On 08/11/2025 the filings show a sale of 4,110 ordinary shares at a weighted average price of $241.96 per share and a related entry reflecting 4,110 ordinary shares associated with a $64.05 price. After the reported transactions, the form lists 22,361 ordinary shares beneficially owned directly by the reporting person.

Separately, on 08/08/2025 the reporting person received equity awards: a nonqualified director stock option to purchase 2,226 ordinary shares at an exercise price of $242.85 (described as fully vested and exercisable immediately), plus career restricted stock units of 772 and 506 ordinary shares. The filing notes the 506 RSUs were issued in lieu of $123,000 in fees and that career RSUs generally settle in ordinary shares six months after cessation of board service. An additional option to purchase 4,110 ordinary shares at $64.05 (fully vested) is also disclosed.

Mohsen Sohi, amministratore di STERIS plc (STE), ha comunicato più operazioni su azioni ad agosto 2025. In data 08/11/2025 i documenti riportano la vendita di 4,110 azioni ordinarie a un prezzo medio ponderato di $241.96 per azione e una voce correlata relativa a 4,110 azioni ordinarie con un prezzo di $64.05. Dopo le operazioni segnalate, il modulo indica che la persona che ha presentato la comunicazione detiene direttamente a titolo beneficiario 22,361 azioni ordinarie.

Separatamente, in data 08/08/2025 la medesima persona ha ricevuto premi in azioni: un'opzione azionaria non qualificata riservata ai direttori per acquistare 2,226 azioni ordinarie a un prezzo di esercizio di $242.85 (completamente maturata ed esercitabile immediatamente), oltre a career restricted stock units per 772 e 506 azioni ordinarie. Il deposito specifica che le 506 RSU sono state emesse in sostituzione di $123,000 in corrispettivi e che le career RSU vengono generalmente liquidate in azioni ordinarie sei mesi dopo la cessazione dell'incarico nel consiglio. È inoltre riportata un'ulteriore opzione per acquistare 4,110 azioni ordinarie a $64.05 (completamente maturata).

Mohsen Sohi, director de STERIS plc (STE), informó varias transacciones de acciones en agosto de 2025. El 08/11/2025 los registros muestran la venta de 4,110 acciones ordinarias a un precio promedio ponderado de $241.96 por acción y una anotación relacionada que refleja 4,110 acciones ordinarias asociadas a un precio de $64.05. Tras las transacciones registradas, el formulario indica que la persona que presentó la declaración posee directamente, a título beneficiario, 22,361 acciones ordinarias.

Por separado, el 08/08/2025 la persona informó haber recibido premios en acciones: una opción sobre acciones no calificada para directores para comprar 2,226 acciones ordinarias a un precio de ejercicio de $242.85 (totalmente adquirida y ejercitable de inmediato), además de unidades restringidas de acciones por trayectoria de 772 y 506 acciones ordinarias. El informe señala que las 506 RSU se emitieron en lugar de $123,000 en honorarios y que las RSU por trayectoria normalmente se liquidan en acciones ordinarias seis meses después de la finalización del cargo en el consejo. También se divulga una opción adicional para comprar 4,110 acciones ordinarias a $64.05 (totalmente adquirida).

Mohsen Sohi, STERIS plc(티커: STE)ì� ì´ì‚¬, ëŠ� 2025ë…� 8ì›� 여러 ì§€ë¶� 거래ë¥� 보고했습니다. 2025-08-11(08/11/2025)ìž� 제출서류ì—는 4,110 보통ì£�ë¥� 주당 가중í‰ê·� $241.96ì—� 매ë„í•� ë‚´ì—­ê³�, 주당 $64.05ë¡� ì—°ê´€ë� 4,110 보통ì£� 항목ì� 기재ë˜ì–´ 있습니다. ë³´ê³ ë� 거래 í›� 제출서류ì—는 ë³´ê³ ì¸ì´ ì§ì ‘ 실질ì ìœ¼ë¡� 보유í•� 보통주가 22,361주로 기재ë˜ì–´ 있습니다.

별ë„ë¡� 2025-08-08(08/08/2025) ë³´ê³ ì¸ì€ ì§€ë¶� ë³´ìƒì� 받았습니ë‹�: 비ì ê²� ì´ì‚¬ìš� 스톡옵션으로 2,226주를 행사가ê²� $242.85ì—� 매수í•� ìˆ� 있는 권리(완전 ì·¨ë“ë˜ì–´ 즉시 행사 ê°€ëŠ�)와, 경력í˜� 제한부주ì‹ë‹¨ìœ„(RSU) 772ì£� ë°� 506주를 받았습니ë‹�. 제출서류ëŠ� 506 RSUê°€ $123,000ì� 수수ë£� 대ì‹� 발행ë˜ì—ˆìŒì„ 명시하고 있으ë©�, 경력í˜� RSUëŠ� ì¼ë°˜ì ìœ¼ë¡� ì´ì‚¬íš� ì§ë¬´ 종료 í›� 6개월 í›„ì— ë³´í†µì£¼ë¡œ ì •ì‚°ëœë‹¤ê³� ë°í˜€ì§‘니ë‹�. ë˜í•œ 주당 $64.05ì� 행사가격으ë¡� 4,110주를 매수í•� ìˆ� 있는 추가 옵션(완전 ì·¨ë“)ë� 공개ë˜ì–´ 있습니다.

Mohsen Sohi, administrateur de STERIS plc (STE), a déclaré plusieurs opérations sur titres en août 2025. Le 08/11/2025, les dépôts montrent la vente de 4,110 actions ordinaires à un prix moyen pondéré de $241.96 par action et une mention connexe faisant état de 4,110 actions ordinaires liées à un prix de $64.05. Après les transactions déclarées, le formulaire indique que la personne déclarante possède directement à titre bénéficiaire 22,361 actions ordinaires.

Séparément, le 08/08/2025 la personne a reçu des attributions en actions : une option d'achat d'actions non qualifiée pour administrateurs portant sur 2,226 actions ordinaires à un prix d'exercice de $242.85 (entièrement acquise et immédiatement exerçable), ainsi que des unités d'actions restreintes de carrière de 772 et 506 actions ordinaires. Le dépôt indique que les 506 RSU ont été émises en lieu et place de $123,000 d'honoraires et que les RSU de carrière sont généralement réglées en actions ordinaires six mois après la fin du mandat au conseil. Une option supplémentaire d'acheter 4,110 actions ordinaires à $64.05 (entièrement acquise) est également divulguée.

Mohsen Sohi, Director bei STERIS plc (STE), meldete mehrere Aktiengeschäfte im August 2025. Am 08/11/2025 zeigen die Einreichungen den Verkauf von 4,110 Stammaktien zu einem gewogenen Durchschnittspreis von $241.96 je Aktie sowie einen zugehörigen Eintrag, der 4,110 Stammaktien mit einem Preis von $64.05 ausweist. Nach den gemeldeten Transaktionen gibt das Formular an, dass die meldende Person direkt wirtschaftlich begünstigt 22,361 Stammaktien besitzt.

Separat erhielt die meldende Person am 08/08/2025 Aktienschweden: eine nicht qualifizierte Optionszuteilung für Direktoren zum Kauf von 2,226 Stammaktien zu einem Ausübungspreis von $242.85 (vollständig erworben und sofort ausübbar) sowie karrierebezogene Restricted Stock Units von 772 und 506 Stammaktien. Die Einreichung weist darauf hin, dass die 506 RSU anstelle von $123,000 an Vergütungen ausgegeben wurden und dass karrierebezogene RSU in der Regel sechs Monate nach Beendigung der Vorstandstätigkeit in Stammaktien abgewickelt werden. Ebenfalls offengelegt wird eine zusätzliche Option zum Kauf von 4,110 Stammaktien zu $64.05 (vollständig erworben).

Positive
  • Receipt of a fully vested nonqualified option to purchase 2,226 ordinary shares at $242.85, exercisable immediately as stated.
  • Career Restricted Stock Units awarded totaling 1,278 ordinary shares (772 and 506), with explicit settlement terms (six months after cessation of board service).
  • 506 RSUs issued in lieu of $123,000 in fees, indicating compensation was converted to equity rather than cash.
Negative
  • Sale of 4,110 ordinary shares on 08/11/2025 at a weighted average price of $241.96, which reduced direct beneficial ownership reported to 22,361 shares.
  • Multiple option and RSU awards create potential future share issuance and dilution (options for 2,226 and 4,110 shares plus 1,278 RSUs disclosed).

Insights

TL;DR: Director sold 4,110 shares while receiving vested options and RSUs; overall impact appears routine and neutral.

The filing documents an insider sale of 4,110 ordinary shares at a weighted average of $241.96, together with contemporaneous recognition of option and RSU awards. The director received a fully vested option for 2,226 shares at $242.85 and career RSUs totaling 1,278 shares (772 and 506). The 506 RSUs were issued in lieu of $123,000 in fees and career RSUs settle six months after board service ceases, which affects timing of potential share issuance. These are consistent with compensation and onboarding/redomiciliation items disclosed in the form, so the disclosure does not, by itself, indicate a material change to the company outlook.

TL;DR: Insider sale plus compensation awards are disclosed; governance implications are routine but warrant monitoring.

The report shows a director-level sale and concurrent grant of equity-based awards. The option grants are noted as fully vested and the career RSUs carry post-service settlement provisions. The filing explicitly states one RSU issuance was in lieu of cash fees, and an additional legacy option tied to redomiciliation is disclosed. While insider sales can prompt investor questions, the form presents standard compensation mechanics and vesting/settlement terms rather than governance irregularities.

Mohsen Sohi, amministratore di STERIS plc (STE), ha comunicato più operazioni su azioni ad agosto 2025. In data 08/11/2025 i documenti riportano la vendita di 4,110 azioni ordinarie a un prezzo medio ponderato di $241.96 per azione e una voce correlata relativa a 4,110 azioni ordinarie con un prezzo di $64.05. Dopo le operazioni segnalate, il modulo indica che la persona che ha presentato la comunicazione detiene direttamente a titolo beneficiario 22,361 azioni ordinarie.

Separatamente, in data 08/08/2025 la medesima persona ha ricevuto premi in azioni: un'opzione azionaria non qualificata riservata ai direttori per acquistare 2,226 azioni ordinarie a un prezzo di esercizio di $242.85 (completamente maturata ed esercitabile immediatamente), oltre a career restricted stock units per 772 e 506 azioni ordinarie. Il deposito specifica che le 506 RSU sono state emesse in sostituzione di $123,000 in corrispettivi e che le career RSU vengono generalmente liquidate in azioni ordinarie sei mesi dopo la cessazione dell'incarico nel consiglio. È inoltre riportata un'ulteriore opzione per acquistare 4,110 azioni ordinarie a $64.05 (completamente maturata).

Mohsen Sohi, director de STERIS plc (STE), informó varias transacciones de acciones en agosto de 2025. El 08/11/2025 los registros muestran la venta de 4,110 acciones ordinarias a un precio promedio ponderado de $241.96 por acción y una anotación relacionada que refleja 4,110 acciones ordinarias asociadas a un precio de $64.05. Tras las transacciones registradas, el formulario indica que la persona que presentó la declaración posee directamente, a título beneficiario, 22,361 acciones ordinarias.

Por separado, el 08/08/2025 la persona informó haber recibido premios en acciones: una opción sobre acciones no calificada para directores para comprar 2,226 acciones ordinarias a un precio de ejercicio de $242.85 (totalmente adquirida y ejercitable de inmediato), además de unidades restringidas de acciones por trayectoria de 772 y 506 acciones ordinarias. El informe señala que las 506 RSU se emitieron en lugar de $123,000 en honorarios y que las RSU por trayectoria normalmente se liquidan en acciones ordinarias seis meses después de la finalización del cargo en el consejo. También se divulga una opción adicional para comprar 4,110 acciones ordinarias a $64.05 (totalmente adquirida).

Mohsen Sohi, STERIS plc(티커: STE)ì� ì´ì‚¬, ëŠ� 2025ë…� 8ì›� 여러 ì§€ë¶� 거래ë¥� 보고했습니다. 2025-08-11(08/11/2025)ìž� 제출서류ì—는 4,110 보통ì£�ë¥� 주당 가중í‰ê·� $241.96ì—� 매ë„í•� ë‚´ì—­ê³�, 주당 $64.05ë¡� ì—°ê´€ë� 4,110 보통ì£� 항목ì� 기재ë˜ì–´ 있습니다. ë³´ê³ ë� 거래 í›� 제출서류ì—는 ë³´ê³ ì¸ì´ ì§ì ‘ 실질ì ìœ¼ë¡� 보유í•� 보통주가 22,361주로 기재ë˜ì–´ 있습니다.

별ë„ë¡� 2025-08-08(08/08/2025) ë³´ê³ ì¸ì€ ì§€ë¶� ë³´ìƒì� 받았습니ë‹�: 비ì ê²� ì´ì‚¬ìš� 스톡옵션으로 2,226주를 행사가ê²� $242.85ì—� 매수í•� ìˆ� 있는 권리(완전 ì·¨ë“ë˜ì–´ 즉시 행사 ê°€ëŠ�)와, 경력í˜� 제한부주ì‹ë‹¨ìœ„(RSU) 772ì£� ë°� 506주를 받았습니ë‹�. 제출서류ëŠ� 506 RSUê°€ $123,000ì� 수수ë£� 대ì‹� 발행ë˜ì—ˆìŒì„ 명시하고 있으ë©�, 경력í˜� RSUëŠ� ì¼ë°˜ì ìœ¼ë¡� ì´ì‚¬íš� ì§ë¬´ 종료 í›� 6개월 í›„ì— ë³´í†µì£¼ë¡œ ì •ì‚°ëœë‹¤ê³� ë°í˜€ì§‘니ë‹�. ë˜í•œ 주당 $64.05ì� 행사가격으ë¡� 4,110주를 매수í•� ìˆ� 있는 추가 옵션(완전 ì·¨ë“)ë� 공개ë˜ì–´ 있습니다.

Mohsen Sohi, administrateur de STERIS plc (STE), a déclaré plusieurs opérations sur titres en août 2025. Le 08/11/2025, les dépôts montrent la vente de 4,110 actions ordinaires à un prix moyen pondéré de $241.96 par action et une mention connexe faisant état de 4,110 actions ordinaires liées à un prix de $64.05. Après les transactions déclarées, le formulaire indique que la personne déclarante possède directement à titre bénéficiaire 22,361 actions ordinaires.

Séparément, le 08/08/2025 la personne a reçu des attributions en actions : une option d'achat d'actions non qualifiée pour administrateurs portant sur 2,226 actions ordinaires à un prix d'exercice de $242.85 (entièrement acquise et immédiatement exerçable), ainsi que des unités d'actions restreintes de carrière de 772 et 506 actions ordinaires. Le dépôt indique que les 506 RSU ont été émises en lieu et place de $123,000 d'honoraires et que les RSU de carrière sont généralement réglées en actions ordinaires six mois après la fin du mandat au conseil. Une option supplémentaire d'acheter 4,110 actions ordinaires à $64.05 (entièrement acquise) est également divulguée.

Mohsen Sohi, Director bei STERIS plc (STE), meldete mehrere Aktiengeschäfte im August 2025. Am 08/11/2025 zeigen die Einreichungen den Verkauf von 4,110 Stammaktien zu einem gewogenen Durchschnittspreis von $241.96 je Aktie sowie einen zugehörigen Eintrag, der 4,110 Stammaktien mit einem Preis von $64.05 ausweist. Nach den gemeldeten Transaktionen gibt das Formular an, dass die meldende Person direkt wirtschaftlich begünstigt 22,361 Stammaktien besitzt.

Separat erhielt die meldende Person am 08/08/2025 Aktienschweden: eine nicht qualifizierte Optionszuteilung für Direktoren zum Kauf von 2,226 Stammaktien zu einem Ausübungspreis von $242.85 (vollständig erworben und sofort ausübbar) sowie karrierebezogene Restricted Stock Units von 772 und 506 Stammaktien. Die Einreichung weist darauf hin, dass die 506 RSU anstelle von $123,000 an Vergütungen ausgegeben wurden und dass karrierebezogene RSU in der Regel sechs Monate nach Beendigung der Vorstandstätigkeit in Stammaktien abgewickelt werden. Ebenfalls offengelegt wird eine zusätzliche Option zum Kauf von 4,110 Stammaktien zu $64.05 (vollständig erworben).

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sohi Mohsen

(Last) (First) (Middle)
70 SIR JOHN ROGERSON'S QUAY

(Street)
DUBLIN 2 L2 D02 R296

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 08/11/2025 M 4,110 A $64.05 26,471 D
Ordinary Shares 08/11/2025 S 4,110 D $241.96(1) 22,361 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Director Stock Option (right to buy) $242.85 08/08/2025 A 2,226 (2) 08/08/2035 Ordinary Shares 2,226 $0 2,226 D
Career Restricted Stock Units (3) 08/08/2025 A 772 (4) (4) Ordinary Shares 772 $0 7,244 D
Career Restricted Stock Units (3) 08/08/2025 A 506 (4) (4) Ordinary Shares 506 $242.85(5) 7,750 D
Director Stock Option (right to buy) $64.05 08/11/2025 M 4,110 (6) 08/31/2025 Ordinary Shares 4,110 $0 0 D
Explanation of Responses:
1. Price reflects a weighted average sale price for multiple transactions ranging from $241.36 to $242.295 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
2. These nonqualified stock options are fully vested and are exercisable immediately.
3. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
4. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
5. These Career Restricted Stock Units were issued to the Reporting Person in lieu of $123,000 in fees.
6. This option to purchase 4,110 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,110 ordinary shares for $64.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.
Remarks:
/s/ John P. Ubbing, Authorized Representative under Power of Attorney 08/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did STERIS (STE) report for Mohsen Sohi?

The filing shows a sale of 4,110 ordinary shares at a weighted average price of $241.96 on 08/11/2025 and equity awards on 08/08/2025 including a 2,226-share option at $242.85 and 772 and 506 career RSUs.

How many shares does the reporting person own after the transactions?

The form lists 22,361 ordinary shares beneficially owned directly following the reported transactions.

Were any awards described as fully vested or exercisable?

Yes. The filing states the 2,226-share nonqualified option is fully vested and exercisable immediately, and the career RSUs are described as fully vested.

Did any RSUs replace cash compensation?

Yes. The filing states that 506 Career Restricted Stock Units were issued to the reporting person in lieu of $123,000 in fees.

Are there any special settlement or exercise conditions disclosed?

Career Restricted Stock Units are stated to be settled in ordinary shares six months after cessation of the director's board service; an option related to redomiciliation is noted with the same original terms.

Is the option associated with redomiciliation described?

Yes. The filing discloses an option to purchase 4,110 ordinary shares at $64.05 that was received in connection with the redomiciliation and is described as fully vested.
Steris Plc

NYSE:STE

STE Rankings

STE Latest News

STE Latest SEC Filings

STE Stock Data

23.92B
98.18M
0.3%
95.58%
0.86%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
United States
DUBLIN